Suzuki Shiro

Research theme for competitive and other funds (6)：

2019 - 2022 Antitumor immune response in patients with endometrial cancer from the perspective of uterine Ecosystem
2019 - 2022 Elucidation of malignancy, peritoneal dissemination and spread mechanism of ovarian cancer by interaction with peritoneal mesothelium.
2017 - 2020 Interdisciplinary research on intraperitoneal cell-to-cell crosstalk focusing ovarian cancer-associated mesothelial cells
2016 - 2019 Analysis of tumor-infiltrating lymphocytes in malignant gynecologic tumors for development of personalized tumor immunotherapy
2012 - 2015 Immunological and clinical analysis of tumor antigen specific immunotherapy combined with chemotherapy against ovarian cancer

Show all

Papers (41)：

Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Yusuke Shimizu, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kaoru Niimi, et al. Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer. Cancer medicine. 2024. 13. 7. e7149
Toshiaki Yoshikawa, Zhiwen Wu, Satoshi Inoue, Hitomi Kasuya, Hirokazu Matsushita, Yusuke Takahashi, Hiroaki Kuroda, Waki Hosoda, Shiro Suzuki, Yuki Kagoya. Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy. Blood. 2022. 139. 14. 2156-2172
Mayu Ukai, Shiro Suzuki, Masato Yoshihara, Akira Yokoi, Nobuhisa Yoshikawa, Hiroaki Kajiyama, Fumitaka Kikkawa. Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary?. International Journal of Clinical Oncology. 2021
Kazuto Nosaka, Shiro Suzuki, Toshiaki Yoshikawa, Manami Shimomura, Kazuhisa Kitami, Kosuke Yoshida, Masato Yoshihara, Fumitaka Kikkawa, Tetsuya Nakatsura, Hiroaki Kajiyama. Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer. Anticancer research. 2021. 41. 10. 4741-4751
Kenichi Nakamura, Kaoru Niimi, Eiko Yamamoto, Yoshiki Ikeda, Kimihiro Nishino, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa. Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity. Biochemistry and biophysics reports. 2021. 26. 100951-100951

ｍore...

MISC (6)：

吉田康将, 横井暁, 玉内学志, 吉原雅人, 芳川修久, 西野公博, 新美薫, 鈴木史朗, 梶山広明, 吉川史隆. 卵巣成熟奇形腫の悪性転化における特徴的なmiRNA発現プロファイルの同定(Identification of unique miRNA profiling in squamous cell carcinoma arising from mature teratoma of ovary). 日本癌学会総会記事. 2019. 78回. P-1350
吉田康将, 横井暁, 玉内学志, 吉原雅人, 芳川修久, 西野公博, 新美薫, 鈴木史朗, 梶山広明, 吉川史隆. 卵巣成熟奇形腫の悪性転化における特徴的なmiRNA発現プロファイルの同定(Identification of unique miRNA profiling in squamous cell carcinoma arising from mature teratoma of ovary). 日本癌学会総会記事. 2019. 78回. P-1350
大野真由, 吉原雅人, 渡邉絵里, 佐藤麻美子, 清水裕介, 野坂和外, 仲西菜月, 吉田康将, 新保暁子, 玉内学志, et al. stageI卵巣明細胞癌における術後化学療法サイクル数に関する検討. 日本婦人科腫瘍学会雑誌. 2019. 37. 3. 452-452
中村謙一, 新美薫, 山本英子, 関谷陽子, 西野公博, 佐藤静香, 菅もも, 藤原多子, 鈴木史朗, 吉川史隆. 血清hCG 100万mIU/ml以上の胞状奇胎の検討. 東海産科婦人科学会雑誌. 2017. 53. 213-220
三井寛子, 柴田清住, 内海史, 新美薫, 関谷龍一郎, 鈴木史朗, 山本英子, 水野美香, 梶山広明, 吉川史隆. Growing Teratoma Syndromeを呈した卵巣未熟奇形腫の2例. 日本産科婦人科学会雑誌. 2015. 67. 2. 695-695

ｍore...

Professional career (1)：

博士(医学) (名古屋大学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page